Immune thrombocytopenic purpura associated with inactive ulcerative colitis in chronic treatment with adalimumab

Gastroenterol Hepatol. 2020 Jan;43(1):28-29. doi: 10.1016/j.gastrohep.2019.07.003. Epub 2019 Sep 2.

[Article in English, Spanish]

Authors

Benito Velayos Jiménez¹, Rebeca Cuello García², Lourdes Del Olmo Martínez³, Ana Macho Conesa³, Luis Fernández Salazar³

Affiliations

¹ Servicio de Aparato Digestivo, Hospital Clínico de Valladolid, Valladolid, España. Electronic address: benitovelayos@hotmail.com.
² Servicio de Hematología, Hospital Clínico de Valladolid, Valladolid, España.
³ Servicio de Aparato Digestivo, Hospital Clínico de Valladolid, Valladolid, España.

PMID: 31488320
DOI: 10.1016/j.gastrohep.2019.07.003

No abstract available

Publication types

Case Reports

MeSH terms

Adalimumab / therapeutic use
Anti-Inflammatory Agents / therapeutic use
Azathioprine / therapeutic use
Blood Transfusion
Colitis, Ulcerative / complications*
Female
Humans
Immunosuppressive Agents / therapeutic use
Middle Aged
Purpura, Thrombocytopenic, Idiopathic / etiology*
Purpura, Thrombocytopenic, Idiopathic / therapy

Substances

Anti-Inflammatory Agents
Immunosuppressive Agents
Adalimumab
Azathioprine